Choosing the Best Treatment Regimen in Multiple Myeloma: Episode 1 - the Newly Diagnosed Setting

Episode 1 October 13, 2021 00:20:43
Choosing the Best Treatment Regimen in Multiple Myeloma: Episode 1 - the Newly Diagnosed Setting
COR2ED Medical Education
Choosing the Best Treatment Regimen in Multiple Myeloma: Episode 1 - the Newly Diagnosed Setting

Oct 13 2021 | 00:20:43

/

Show Notes

In this medical education podcast series, myeloma experts Dr. Joshua Richter (Assistant Professor of Medicine and Director of Myeloma at the Tisch Cancer Institute at the Icahn School of Medicine and the Blavatnik Family Chelsea Medical Center at Mount Sinai in New York, USA) and Dr. Karthik Ramasamy (Haematologist and Associate Professor of Haematology at the Oxford University Hospitals in London, UK) discuss their experience and views on choosing the best treatment every time in multiple myeloma.

In this first episode, Dr. Richter and Dr. Ramasamy discuss how to select the best approach in newly diagnosed patients with multiple myeloma. The experts look at transplant eligibility as one of the key factors in deciding which treatment to start with in the front-line setting. They discuss the potential for personalising therapy in newly diagnosed patients, both in the transplant setting as well as in patients who are not eligible for transplantation.

They also comment on the impact of MRD negativity in clinical practice and agree that the goal of treatment is to induce deep remissions. However, which patient needs triple or quadruplet therapy to achieve this goal is still unclear and the risk-benefit profile needs to be considered for each individual patient.

The final topic that the experts share their points of view on is continuous vs fixed-duration maintenance therapy.

Other Episodes

Episode 2

February 07, 2022 00:24:43
Episode Cover

PARP inhibitors in prostate cancer: What nurses need to know

COR2ED Medical Education: Pablo Peinado, Research Nurse Coordinator, and Dr. Elena Castro, medical oncologist, who both work at Hospital Universitario Virgen de la Victoria...

Listen

Episode 2

October 03, 2021 00:16:30
Episode Cover

ASBMR 2021 Rare Bone Disease Highlights from Day Two

We have partnered with international experts to provide rare bone diseases highlights from ASBMR 2021. This is the second in a series of four...

Listen

Episode 1

December 14, 2022 00:19:51
Episode Cover

Clinical implementation of targeted and immunotherapies for advanced RCC

Prof. Thomas Powles, a Medical Oncologist from Barts Cancer Centre in the UK and Dr Friederike Schlürmann a Medical Oncologist from University Hospital of...

Listen